Alexandria, VA – June 5, 2026 – The American Association for the Study of Liver Diseases (AASLD) proudly announces the 2026 Distinguished Award recipients, honoring individuals whose outstanding contributions have shaped the field of hepatology and advanced the care of patients with liver disease.
Each year, AASLD presents its most prestigious awards to recognize exceptional leadership, mentorship, service, and advocacy across the liver community.
The 2026 honorees include:
Distinguished Achievement Award
Pere Ginès, MD, FAASLD
University of Barcelona, Spain
Distinguished Clinician Educator/Mentor Award
Tamar Taddei, MD, FAASLD
Yale University, Connecticut
Distinguished Service Award
Frank Anania, MD, FAASLD
U.S. Food and Drug Administration, Maryland
Distinguished Advocacy Award
Ricky Safer
CEO and Founder of PSC Partners Seeking a Cure, Colorado
To view the awardee profiles, as well as previous Distinguished Award recipients, click here.
These awardees will be recognized and celebrated at The Liver Meeting® (TLM) in Denver, Colorado during the Awards & Honors Gala on Saturday, Nov. 7. To learn more about TLM 2026, click here.
###
About AASLD
The American Association for the Study of Liver Diseases (AASLD), founded in 1950, is the leading global organization of scientists and health care professionals dedicated to advancing the science and practice of hepatology and improving liver health for all. Through cutting-edge research, professional education, practice guidance, advocacy, and collaboration, AASLD works to prevent, treat, and ultimately cure liver disease. The association supports a vibrant, multidisciplinary community committed to driving innovation and improving patient outcomes worldwide. Learn more at www.aasld.org.